Your browser doesn't support javascript.
loading
Characterisation of age and polarity at onset in bipolar disorder.
Kalman, Janos L; Olde Loohuis, Loes M; Vreeker, Annabel; McQuillin, Andrew; Stahl, Eli A; Ruderfer, Douglas; Grigoroiu-Serbanescu, Maria; Panagiotaropoulou, Georgia; Ripke, Stephan; Bigdeli, Tim B; Stein, Frederike; Meller, Tina; Meinert, Susanne; Pelin, Helena; Streit, Fabian; Papiol, Sergi; Adams, Mark J; Adolfsson, Rolf; Adorjan, Kristina; Agartz, Ingrid; Aminoff, Sofie R; Anderson-Schmidt, Heike; Andreassen, Ole A; Ardau, Raffaella; Aubry, Jean-Michel; Balaban, Ceylan; Bass, Nicholas; Baune, Bernhard T; Bellivier, Frank; Benabarre, Antoni; Bengesser, Susanne; Berrettini, Wade H; Boks, Marco P; Bromet, Evelyn J; Brosch, Katharina; Budde, Monika; Byerley, William; Cervantes, Pablo; Chillotti, Catina; Cichon, Sven; Clark, Scott R; Comes, Ashley L; Corvin, Aiden; Coryell, William; Craddock, Nick; Craig, David W; Croarkin, Paul E; Cruceanu, Cristiana; Czerski, Piotr M; Dalkner, Nina.
Afiliación
  • Kalman JL; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; and International Max Planck Research School for Translational Psychiatry, Germany.
  • Olde Loohuis LM; Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, USA.
  • Vreeker A; Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre-Sophia Children's Hospital, the Netherlands.
  • McQuillin A; Division of Psychiatry, University College London, UK.
  • Stahl EA; Division of Psychiatric Genomics, Mount Sinai School of Medicine, USA.
  • Ruderfer D; Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, USA; and Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center,
  • Grigoroiu-Serbanescu M; Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania.
  • Panagiotaropoulou G; Department of Psychiatry and Psychotherapy, Charite - Universitätsmedizin, Germany.
  • Ripke S; Analytic and Translational Genetics Unit, Massachusetts General Hospital, USA; and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, USA.
  • Bigdeli TB; Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, USA; and VA NY Harbor Healthcare System, USA.
  • Stein F; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.
  • Meller T; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; and Center for Mind, Brain and Behavior (CMBB), Germany.
  • Meinert S; Institute for Translational Psychiatry, Westfälische Wilhelms-Universität Münster, Germany; and Institute for Translational Neuroscience, University of Münster, Germany.
  • Pelin H; International Max Planck Research School for Translational Psychiatry, Germany; and Max Planck Institute of Psychiatry, Germany.
  • Streit F; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.
  • Papiol S; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; and Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Spain.
  • Adams MJ; Division of Psychiatry, University of Edinburgh, UK.
  • Adolfsson R; Department of Clinical Sciences, Medical Faculty, Umeå University, Sweden.
  • Adorjan K; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; and Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany.
  • Agartz I; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Sweden; Department of Psychiatric Research, Diakonhjemmet Hospital, Norway; and NORMENT Centre, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Norway.
  • Aminoff SR; Division of Mental Health and Addiction, Oslo University Hospital, Norway; and NORMENT Centre, Inst of Clinical Medicine, University of Oslo, Norway.
  • Anderson-Schmidt H; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Germany.
  • Andreassen OA; NORMENT Centre, Inst of Clinical Medicine, University of Oslo, Norway; and Division of Mental Health and Addiction, Oslo University Hosptial, Norway.
  • Ardau R; Unit of Clinical Pharmacology, University Hospital Agency of Cagliari, Italy.
  • Aubry JM; Faculty of medicine, University of Geneva, Switzerland; and Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.
  • Balaban C; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.
  • Bass N; Division of Psychiatry, University College London, UK.
  • Baune BT; Department of Psychiatry, University of Münster, Germany; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Australia; and Discipline of Psychiatry, Adelaide Medical School,
  • Bellivier F; Universite de Paris, France; INSERM UMRS 1144, France; and DMU Neurosciences, GHU Lariboisière Fernand Widal, Departement de Psychiatrie, APHP, France.
  • Benabarre A; Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain.
  • Bengesser S; Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Austria.
  • Berrettini WH; Psychiatry, University of Pennsylvania, USA.
  • Boks MP; Psychiatry, UMC Utrecht Brain Center, the Netherlands.
  • Bromet EJ; Department of Psychiatry, Stony Brook University, USA.
  • Brosch K; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.
  • Budde M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.
  • Byerley W; Psychiatry, University of California San Francisco, USA.
  • Cervantes P; Department of Psychiatry, McGill University, Canada.
  • Chillotti C; Unit of Clinical Pharmacology, University Hospital Agency of Cagliari, Italy.
  • Cichon S; Department of Biomedicine, University of Basel, Switzerland; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Germany; Institute of Medical Genetics and Pathology, University Hospital Basel, Switzerland; and Institute of Neuroscience and Medicine (I
  • Clark SR; Discipline of Psychiatry, University of Adelaide, Australia; and Bazil Hetzel Institute, Australia.
  • Comes AL; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; and International Max Planck Research School for Translational Psychiatry, Germany.
  • Corvin A; Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College Dublin, Ireland.
  • Coryell W; University of Iowa Hospitals and Clinics, USA.
  • Craddock N; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.
  • Craig DW; Translational Genomics, USC, USA.
  • Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, USA.
  • Cruceanu C; Department of Translational Research, Max Planck Institute of Psychiatry, Germany.
  • Czerski PM; Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poland.
  • Dalkner N; Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Austria.
Br J Psychiatry ; 219(6): 659-669, 2021 12.
Article en En | MEDLINE | ID: mdl-35048876
ABSTRACT

BACKGROUND:

Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools.

AIMS:

To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics.

METHOD:

Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts.

RESULTS:

Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (ß = -0.34 years, s.e. = 0.08), major depression (ß = -0.34 years, s.e. = 0.08), schizophrenia (ß = -0.39 years, s.e. = 0.08), and educational attainment (ß = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO.

CONCLUSIONS:

AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Trastorno Depresivo Mayor / Trastorno del Espectro Autista Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Br J Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Trastorno Depresivo Mayor / Trastorno del Espectro Autista Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Br J Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Alemania